PT-141 (Bremelanotide) is a synthetic research peptide that has been studied for its activity as a melanocortin receptor agonist, with pre-clinical and early clinical investigation exploring its influence on central nervous system arousal pathways.
Unlike traditional vascular-acting compounds, research indicates its primary signalling is brain-mediated rather than blood-flow dependent, making it a distinct area of study in libido and neuro-arousal research.
This compound is referenced strictly in the context of laboratory and pre-clinical research and is supplied for research purposes only, not for human consumption.

Reviews
There are no reviews yet.